RNN is up!
原因:
1. 高盛小型股投资研究认为RNN是买进机会。
2. RNN将于4月20日在美国癌症协会展示其新抗癌药的进展。
In the Goldman Select Research report on the Company, analyst Rob Goldman outlines his thesis for what he describes as a buying opportunity following the recent sell-off.
http://finance.yahoo.com/news/Goldman-Small-Cap-Research-pz-1625708144.html?x=0&.v=1
医药股投资,信息分享,Momentum交易,恭喜发财!风险自负。
原因:
1. 高盛小型股投资研究认为RNN是买进机会。
2. RNN将于4月20日在美国癌症协会展示其新抗癌药的进展。
In the Goldman Select Research report on the Company, analyst Rob Goldman outlines his thesis for what he describes as a buying opportunity following the recent sell-off.
http://finance.yahoo.com/news/Goldman-Small-Cap-Research-pz-1625708144.html?x=0&.v=1
医药股投资,信息分享,Momentum交易,恭喜发财!风险自负。